| Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review T Fiolet, Y Kherabi, CJ MacDonald, J Ghosn, N Peiffer-Smadja Clinical Microbiology and Infection 28 (2), 202-221, 2022 | 676 | 2022 |
| Type 1 interferons as a potential treatment against COVID-19 E Sallard, FX Lescure, Y Yazdanpanah, F Mentre, N Peiffer-Smadja Antiviral research 178, 104791, 2020 | 593 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 380 | 2021 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet Infectious Diseases 22 (2), 209-221, 2022 | 305 | 2022 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 294 | 2021 |
| Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis T Fiolet, A Guihur, ME Rebeaud, M Mulot, N Peiffer-Smadja, ... Clinical microbiology and infection 27 (1), 19-27, 2021 | 278 | 2021 |
| Machine learning for clinical decision support in infectious diseases: a narrative review of current applications N Peiffer-Smadja, TM Rawson, R Ahmad, A Buchard, P Georgiou, ... Clinical Microbiology and Infection 26 (5), 584-595, 2020 | 255 | 2020 |
| Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians A Maury, A Lyoubi, N Peiffer-Smadja, T De Broucker, E Meppiel Revue neurologique 177 (1-2), 51-64, 2021 | 227 | 2021 |
| Open science saves lives: lessons from the COVID-19 pandemic L Besançon, N Peiffer-Smadja, C Segalas, H Jiang, P Masuzzo, C Smout, ... BMC Medical Research Methodology 21 (1), 1-18, 2021 | 225 | 2021 |
| Neurologic manifestations associated with COVID-19: a multicentre registry E Meppiel, N Peiffer-Smadja, A Maury, I Bekri, C Delorme, V Desestret, ... Clinical Microbiology and Infection 27 (3), 458-466, 2021 | 155 | 2021 |
| Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies Y Mahamat-Saleh, T Fiolet, ME Rebeaud, M Mulot, A Guihur, D El Fatouhi, ... BMJ open 11 (10), e052777, 2021 | 133 | 2021 |
| Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre N Peiffer-Smadja, JC Lucet, G Bendjelloul, L Bouadma, S Gerard, ... Clinical Microbiology and Infection 26 (6), 669-672, 2020 | 133 | 2020 |
| Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study M Mailhe, AL Beaumont, M Thy, D Le Pluart, S Perrineau, ... Clinical Microbiology and Infection 29 (2), 233-239, 2023 | 130 | 2023 |
| Omicron SARS-CoV-2 variant: What we know and what we don’t VM Ferré, N Peiffer-Smadja, B Visseaux, D Descamps, J Ghosn, ... Anaesthesia, critical care & pain medicine 41 (1), 100998, 2022 | 128 | 2022 |
| Review of trials currently testing treatment and prevention of COVID-19 PC Fragkou, D Belhadi, N Peiffer-Smadja, CD Moschopoulos, FX Lescure, ... Clinical Microbiology and Infection 26 (8), 988-998, 2020 | 108 | 2020 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 105 | 2022 |
| Assessment of air contamination by SARS-CoV-2 in hospital settings G Birgand, N Peiffer-Smadja, S Fournier, S Kerneis, FX Lescure, JC Lucet JAMA network open 3 (12), e2033232-e2033232, 2020 | 103 | 2020 |
| An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 F Ader, N Peiffer-Smadja, J Poissy, M Bouscambert-Duchamp, D Belhadi, ... Clinical microbiology and infection 27 (12), 1826-1837, 2021 | 96 | 2021 |
| Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis T Fiolet, A Guihur, M Rebeaud, M Mulot, N Peiffer-Smadja, ... Clin Microbiol Infect 27, 19-27, 2020 | 77* | 2020 |
| Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia N Peiffer-Smadja, L Bouadma, V Mathy, K Allouche, J Patrier, M Reboul, ... Critical care 24, 1-10, 2020 | 74 | 2020 |
